Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Henlius Biotech (2696 HK)
Watchlist
116
Analysis
Health Care
•
China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Henlius Biotech
•
23 May 2024 17:09
Henlius (2696 HK): Privatisation by Fosun Pharma?
The shares are 62% below the IPO price. However, shareholders with blocking stakes would welcome an offer suggesting a 30-40% takeover premium...
Arun George
Follow
358 Views
Share
bullish
•
Shanghai Henlius Biotech
•
23 May 2024 14:40
Henlius Biotech (2696 HK): Fosun Offer?
IF Fosun wants to take the company private, an Offer Price of $26/share, may get the job done. $30/share would be optically be more preferable.
David Blennerhassett
Follow
349 Views
Share
bullish
•
China Traditional Chinese Medicine
•
24 Aug 2024 15:00
(Mostly) Asia-Pac M&A: APM Human Services, TCM, Alps Logistics, Fancl, Jeisys Medical, PropertyGuru
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
141 Views
Share
bullish
•
Shanghai Henlius Biotech
•
02 May 2024 19:34
•
Broker
Henlius Biotech (2696 HK) - Strong Product Sales in 1Q
Strong sales maintained in 1Q24. Henlius Biotech (Henlius) recorded total revenue of RMB1.349bn in 1Q24, up 35% YoY. Of this, HANQUYOU’s sales in...
CMB International
Follow
155 Views
Share
bullish
•
Shanghai Henlius Biotech
•
25 Mar 2024 20:52
•
Broker
Henlius Biotech (2696 HK) - Anticipating Sustained Profitability
Henliu’s FY23 revenue increased 67.8% YoY to RMB5.40bn, driven by strong sales of HANQUYOU (trastuzumab biosimilar) and serplulimab (PD-1).
CMB International
Follow
149 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x